HIV-1 COAT PROTEIN GP120-INDUCED INCREASES IN LEVELS OF INTRASYNAPTOSOMAL CALCIUM

被引:34
作者
NATH, A
PADUA, RA
GEIGER, JD
机构
[1] UNIV MANITOBA,FAC MED,DEPT PHYSIOL,WINNIPEG,MB R3E 0W3,CANADA
[2] UNIV MANITOBA,FAC MED,DEPT MED MICROBIOL,WINNIPEG,MB R3E 0W3,CANADA
[3] UNIV MANITOBA,FAC MED,DEPT INTERNAL MED,NEUROL SECT,WINNIPEG,MB R3E 0W3,CANADA
关键词
HIV-1; GP120; CALCIUM; SYNAPTOSOME; GLUTAMATE; DANTROLENE; CALCIUM CHANNEL BLOCKER;
D O I
10.1016/0006-8993(95)00185-S
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of human immunodeficiency virus type-1 (HIV-1) coat protein gp120 on levels of intrasynaptosomal calcium ([Ca2+](i)) were determined in rat cortical synaptosomes. gp120 at concentrations of greater than or equal to 400 pM, significantly (P < 0.05) increased levels of [Ca2+](i). Treatment with 20 mM KCl, reduced the concentrations of gp120 necessary to produce significant (P < 0.001) increases in [Ca2+](i). gp120-evoked increases in [Ca2+](i) were prevented either by treatment with dantrolene or by removal of extracellular calcium with BAPTA. The peak levels of gp120-induced increases in [Ca2+](i) were not affected by calcium channel blockers lanthanum and nicardipine, by glutamate receptor antagonists MK-801 and NBQX, or by removal of endogenous glutamate with glutamate dehydrogenase. gp120-induced [Ca2+](i) increases in presynaptic terminals may play a role in HIV-mediated effects in the central nervous system.
引用
收藏
页码:200 / 206
页数:7
相关论文
共 38 条
[1]   ENVELOPE GLYCOPROTEIN GP120 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ALTERS ION-TRANSPORT IN ASTROCYTES - IMPLICATIONS FOR AIDS DEMENTIA COMPLEX [J].
BENOS, DJ ;
HAHN, BH ;
BUBIEN, JK ;
GHOSH, SK ;
MASHBURN, NA ;
CHAIKIN, MA ;
SHAW, GM ;
BENVENISTE, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :494-498
[2]  
BERTON EW, 1992, AIDS RES HUM RETROV, V8, P495
[3]   NEURONAL CELL KILLING BY THE ENVELOPE PROTEIN OF HIV AND ITS PREVENTION BY VASOACTIVE INTESTINAL PEPTIDE [J].
BRENNEMAN, DE ;
WESTBROOK, GL ;
FITZGERALD, SP ;
ENNIST, DL ;
ELKINS, KL ;
RUFF, MR ;
PERT, CB .
NATURE, 1988, 335 (6191) :639-642
[4]  
CHUEH SH, 1994, AM J PHYSIOL, V266, pC1006
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT PROTEIN NEUROTOXICITY MEDIATED BY NITRIC-OXIDE IN PRIMARY CORTICAL CULTURES [J].
DAWSON, VL ;
DAWSON, TM ;
UHL, GR ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3256-3259
[6]   HIV-1 COAT PROTEIN NEUROTOXICITY PREVENTED BY CALCIUM-CHANNEL ANTAGONISTS [J].
DREYER, EB ;
KAISER, PK ;
OFFERMANN, JT ;
LIPTON, SA .
SCIENCE, 1990, 248 (4953) :364-367
[7]   LEARNING IMPAIRMENT FOLLOWING INTRACEREBRAL ADMINISTRATION OF THE HIV ENVELOPE PROTEIN GP120 OR A VIP ANTAGONIST [J].
GLOWA, JR ;
PANLILIO, LV ;
BRENNEMAN, DE ;
GOZES, I ;
FRIDKIN, M ;
HILL, JM .
BRAIN RESEARCH, 1992, 570 (1-2) :49-53
[8]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[9]  
HAYASHI T, 1994, J NEUROCHEM, V63, P1849
[10]   NEUROTOXICITY OF PEPTIDE ANALOGS OF THE TRANSACTIVATING PROTEIN TAT FROM MAEDI-VISNA VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS [J].
HAYMAN, M ;
ARBUTHNOTT, G ;
HARKISS, G ;
BRACE, H ;
FILIPPI, P ;
PHILIPPON, V ;
THOMSON, D ;
VIGNE, R ;
WRIGHT, A .
NEUROSCIENCE, 1993, 53 (01) :1-6